Kang Seok-ho

専門分野: Urologist
19年の経験
話します:
Korean
勤務先: 大韓民国, ソウル, Korea University Anam Hospital
アジアで初めてロボット支援による定位的膀胱置換術、ロボット支援による拡張型骨盤リンパ節郭清術、およびロボット技術を用いた尿路変更術を執刀。
カン・ソクホ医師は、ソウルの高麗大学安岩病院の泌尿器科医です。アジアにおける外科手術技術のパイオニアであり、アジアで初めてロボット支援による定位的膀胱置換術を執刀しました。また、同地域にロボット支援による尿路変更術を導入しました。膀胱がん、前立腺がん、腎臓がんに対するロボット支援腫瘍学を専門としています。
- 高麗大学安岩病院ロボット手術センター長を歴任。
- 韓国泌尿器腫瘍学会の泌尿器科部長を務めた。
- 南カリフォルニア大学泌尿器科研究所で外科研究を修了。
- JCI認定施設にて、ダビンチ・ロボット支援前立腺全摘除術および腎摘除術を行う。

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Prof. Kang Seok-ho is a urologist who performs robotic surgery. He was the first in Asia to perform robotic stereotactic bladder replacement and expandable pelvic lymphadenectomy. Dr. Kang currently directs the Robot Surgery Center at Korea University Anam Hospital.

Robotic Surgery Achievements

Dr. Kang uses robotic techniques for urological cancers and conditions. He achieved several regional firsts using robotic technology. These milestones include performing Asia's first robotic stereotactic bladder replacement in 2007. He followed this in 2008 by performing the first robotic expandable pelvic lymphadenectomy in the region.

In 2011, he completed Asia's first urinary tract diversion performed entirely within the robot body. He also performs procedures including robotic da Vinci prostatectomy, nephrectomy, and prostatectomy. His work aims to improve surgical precision and patient recovery times.

2007 – Asia's first robotic stereotactic bladder replacement.
2008 – Asia's first robotic expandable pelvic lymphadenectomy.
2011 – Asia's first urinary tract diversion performed entirely within the robot body.

Professional Experience

2015–Present – Head of Robot Surgery Center, Korea University Anam Hospital.
2013–Present – Chief of Genito-Urology, Korea University Anam Hospital.
2013–Present – Director, The Korean Urological Oncology Society.
2011–2012 – Research Scholar, Institute of Urology, University of Southern California.

Education and Research

The specialist completed a research fellowship at the University of Southern California. This scholarship focused on urological techniques at the institute. Dr. Kang now applies these standards to treat bladder and prostate cancers.